Nutraceutical and Ayurvedic
Clinical Research

We provide comprehensive testing of nutraceuticals to ensure safety, quality, and regulatory compliance with FSSAI, US Dietary Supplement regulations, Health Canada (Natural Health Supplements), and Australia’s Therapeutic Goods Administration (TGA) standards. Our Services include safety and tolerability assessments, efficacy evaluations, pharmacokinetic and bioavailability studies, and therapeutic claim substantiation across diverse nutraceutical categories. Additionally, we support evaluation of therapeutic label claims, detailed ingredient understanding, and product design optimization. These evidence-based insights help ensure accurate labeling, refined formulations, and market-ready products that meet global standards.

  • Post Marketing Observational Studies

    Conduct real-world surveillance to monitor product safety, effectiveness, and consumer usage patterns, providing critical data for risk management and regulatory compliance.

  • Real World Evidence Studies

    Utilize real-world data sources to generate clinically meaningful insights that support health outcomes research, value demonstration, and market access strategies.

  • Safety, Efficacy, In-Use Tolerability Claims Substantiation

    Execute scientifically validated assessments to substantiate product claims, ensuring alignment with global regulatory standards and market expectations.

  • Clinical Trial Management

    Provide end-to-end clinical trial services, including study design, site coordination, monitoring, data management, and regulatory reporting, ensuring data integrity and compliance.

  • Remote Monitoring

    Leverage cutting-edge technology to facilitate remote patient monitoring and decentralized clinical trial operations, enhancing efficiency and patient-centricity.

NovoBliss Research offers scientifically rigorous Ayurvedic clinical research solutions that bridge traditional wisdom with modern regulatory and clinical standards. With deep domain expertise in AYUSH systems, we support your product development and post market lifecycle through evidence generation, submission ready data, and optimized patient centred studies. As per AYUSH Guideline we offer various types of studies designed to evaluate traditional medicine systems like Ayurveda, Yoga & Naturopathy, Unani, Siddha, and Homeopathy.

  • Phase I – Phase IV Studies

    Support product development through every clinical stage with scientifically designed studies assessing safety, efficacy, dosage, and long-term outcomes.

  • Therapeutic Confirmatory / Efficacy & Safety Studies

    Demonstrate therapeutic value and establish comprehensive safety profiles through controlled, statistically powered clinical evaluations.

  • Post-Marketing / Real-World Evidence (RWE) Studies

    Generate real-world data on long-term safety, effectiveness, and patient outcomes to support continued market access and regulatory compliance.

  • Observational & Non-Interventional Studies

    Capture real-world usage patterns, clinical outcomes, and patient-reported experiences without altering standard treatment practices.

  • Comparative and Controlled Clinical Trials

    Benchmark new interventions against placebo or standard of care to validate superior efficacy, safety, or added clinical benefit.

  • In-Use Tolerability and Safety Substantiation Studies

    Assess real-world safety, tolerability, and user experience using validated scales, AE monitoring, and objective clinical measures.

  • Consumer Perception and Claim Validation Studies

    Substantiate marketing and label claims through evidence-based evaluation of user satisfaction, acceptance, and perceived benefits.

  • Device, Cosmetic, Nutraceutical & Herbal Product Trials

    Establish safety, performance, and functional benefits across diverse product categories under controlled and real-use conditions.

  • Multi-Centric and Global Clinical Trials

    Deliver globally compliant, multi-site data to support international regulatory submissions and product commercialization.

  • Epidemiological and Long-Term Safety Studies

    Track population-level outcomes, long-term safety signals, and effectiveness trends over extended post-marketing periods